Log in

Relevant bibliographies by topics / FDG (fluoro-deoxy glucose)

Contents

Journal articles
Book chapters
Conference papers

Academic literature on the topic 'FDG (fluoro-deoxy glucose)'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'FDG (fluoro-deoxy glucose).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "FDG (fluoro-deoxy glucose)"

1

Videnovic-Ivanov, Jelica, Dragana Sobic-Saranovic, Isidora Grozdic, Violeta Mihailovic-Vucinic, Snezana Filipovic, and Mihailo Stjepanovic. "The application results of 18F - FDG/PET scan in chronic sarcoidosis." Medical review 66, suppl. 1 (2013): 50–53. http://dx.doi.org/10.2298/mpns13s1050v.

Full text

Abstract:

Introduction. The authors evaluated the application of 18 Ffluoro-2-deoxy-D: -glucose positron emission tomography/computed tomography to diagnose the activity in patients with chronic sarcoidosis. Material and Methods. The study sample included 71 patients (48 females and 23 males, their mean age being 47?3 years) with biopsy-proven sarcoidosis of chronic course. Results. All patients underwent 18 F-fluoro-2-deoxy-D: -glucose positron emission tomography/computed tomography, which detected inflammation in 65 patients (91.5%) (maximum standardized uptake value, 8.1 ? 3.9). Angiotensin-converti

APA, Harvard, Vancouver, ISO, and other styles

2

Yu, Amy S., Bruce A. Hirayama, Gerald Timbol, et al. "Functional expression of SGLTs in rat brain." American Journal of Physiology-Cell Physiology 299, no. 6 (2010): C1277—C1284. http://dx.doi.org/10.1152/ajpcell.00296.2010.

Full text

Abstract:

This work provides evidence of previously unrecognized uptake of glucose via sodium-coupled glucose transporters (SGLTs) in specific regions of the brain. The current understanding of functional glucose utilization in brain is largely based on studies using positron emission tomography (PET) with the glucose tracer 2-deoxy-2-[F-18]fluoro-d-glucose (2-FDG). However, 2-FDG is only a good substrate for facilitated-glucose transporters (GLUTs), not for SGLTs. Thus, glucose accumulation measured by 2-FDG omits the role of SGLTs. We designed and synthesized two high-affinity tracers: one, α-methyl-4

APA, Harvard, Vancouver, ISO, and other styles

3

Medak, Adrianna, Julia Wojtowicz, Katarzyna Pietrasz, et al. "Użyteczność badania 18F-FDG PET/CT w diagnostyce guzów pierwotnych i przerzutów nowotworowych do mózgu." Letters in Oncology Science 17, no. 3 (2020): 1–7. http://dx.doi.org/10.21641/los.2020.17.3.183.

Full text

Abstract:

Celem niniejszej pracy jest wykazanie, że mimo nieswoistego charakteru radiofarmaceutyku 2-deoxy-2-[18F]fluoro-D-glukozy (z ang. 2-deoxy-2-[18F]fluoro-D-glucose, 18F-FDG), badanie pozytonowej tomografii emisyjnej/tomografii komputerowej (z ang. positron emission tomography/computed tomography, PET/CT) z użyciem 18F-FDG pozwala wykryć guzy pierwotne i przerzuty nowotworowe do mózgu, co może znacząco wpłynąć na protokół terapeutyczny i jakość życia chorego onkologicznie.

APA, Harvard, Vancouver, ISO, and other styles

4

Wienhard, K., G. Pawlik, B. Nebeling, et al. "Estimation of Local Cerebral Glucose Utilization by Positron Emission Tomography: Comparison of [18F]2-Fluoro-2-Deoxy-D-Glucose and [18F]2-Fluoro-2-Deoxy-D-Mannose in Patients with Focal Brain Lesions." Journal of Cerebral Blood Flow & Metabolism 11, no. 3 (1991): 485–91. http://dx.doi.org/10.1038/jcbfm.1991.92.

Full text

Abstract:

A comparative PET study of [18F]2-fluoro-2-deoxy-D-glucose (FDG) and [18F]2-fluoro-2-deoxy-D-mannose (FDM) uptake was performed in 13 patients with focal brain lesions. Differences between FDG and FDM with respect to model rate constants, lumped constant, and estimated metabolic rate for glucose were determined on a regional basis. Across whole brain, the transport rate constant K*1 was almost unchanged, whereas k*2, describing the transport back from tissue to plasma, was 6% higher, and the phosphorylation rate constant k*3 was 9% lower for FDM compared to FDG. This implies a 20% lower lumped

APA, Harvard, Vancouver, ISO, and other styles

5

Penna, Patricia Sola, Sergio Augusto Lopes De Souza, Paulo Gustavo Limeira Nobre De Lacerda, et al. "Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose." PLOS Neglected Tropical Diseases 17, no. 6 (2023): e0011383. http://dx.doi.org/10.1371/journal.pntd.0011383.

Full text

Abstract:

Background Leprosy is caused by multiple interactions between Mycobacterium leprae (M. leprae) and the host’s peripheral nerve cells. M. leprae primarily invades Schwann cells, causing nerve damage and consequent development of disabilities. Despite its long history, the pathophysiological mechanisms of nerve damage in the lepromatous pole of leprosy remain poorly understood. This study used the findings of 18F-FDG PET/CT on the peripheral nerves of eight lepromatous patients to evaluate the degree of glucose uptake by peripheral nerves and compared them with clinical, electrophysiological, an

APA, Harvard, Vancouver, ISO, and other styles

6

Nguyen, V. T., K. A. Mossberg, T. J. Tewson, et al. "Temporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucose." American Journal of Physiology-Heart and Circulatory Physiology 259, no. 4 (1990): H1022—H1031. http://dx.doi.org/10.1152/ajpheart.1990.259.4.h1022.

Full text

Abstract:

To assess kinetic changes of myocardial glucose metabolism after physiological interventions, we perfused isolated working rat hearts with glucose and 2-[18F]fluoro-2-deoxy-D-glucose (2-FDG). Tissue uptake of 2-FDG and the input function were measured on-line by external detection. The fractional rate of 2-FDG phosphorylation was determined by graphical analysis of time-activity curves. The steady-state uptake of 2-FDG was linear with time, and the tracer was retained predominantly in its phosphorylated form. Tissue accumulation of 2-FDG decreased with a reduction in work load and with the add

APA, Harvard, Vancouver, ISO, and other styles

7

Cauchon, Nicole, Haroutioun M. Hasséssian, Eric Turcotte, Roger Lecomte, and Johan E. van Lier. "Deciphering PDT-induced inflammatory responses using real-time FDG-PET in a mouse tumour model." Photochem. Photobiol. Sci. 13, no. 10 (2014): 1434–43. http://dx.doi.org/10.1039/c4pp00140k.

Full text

Abstract:

Dynamic positron emission tomography (PET), combined with constant infusion of 2-deoxy-2-[<sup>18</sup>F]fluoro-d-glucose (FDG), enables real-time monitoring of transient metabolic changesin vivo, which can serve to understand the underlying physiology.

APA, Harvard, Vancouver, ISO, and other styles

8

Huellner, M. W., M. Cousin, T. Linder, et al. "Melanoma of the middle ear: initial presentation, Fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography imaging and follow up." Journal of Laryngology & Otology 125, no. 5 (2011): 536–39. http://dx.doi.org/10.1017/s0022215110002872.

Full text

Abstract:

AbstractBackground:We present a rare case of primary mucosal melanoma of the middle ear imaged with 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (FDG-PET/CT).Method:Clinical, radiological, intra-operative and histological findings are discussed.Results:An 88-year-old woman presented with intermittent otorrhoea of the left ear for several months. Otoscopy revealed a livid protrusion of the tympanic membrane. Melanoma was not suspected initially, but was established on transmembranous biopsy. Pre-operative 18F-fluoro-2-deoxy-d-glucose positron emission tomography

APA, Harvard, Vancouver, ISO, and other styles

9

Shin, Young Shik, Jungwoo Kim, Dazy Johnson, et al. "Quantitative assessments of glycolysis from single cells." TECHNOLOGY 03, no. 04 (2015): 172–78. http://dx.doi.org/10.1142/s2339547815200058.

Full text

Abstract:

The most common positron emission tomography (PET) radio-labeled probe for molecular diagnostics in patient care and research is the glucose analog, 2-deoxy-2-[F-18]fluoro-D-glucose (18F-FDG). We report on an integrated microfluidics-chip/beta particle imaging system for in vitro 18F-FDG radioassays of glycolysis with single cell resolution. We investigated the kinetic responses of single glioblastoma cancer cells to targeted inhibitors of receptor tyrosine kinase signaling. Further, we find a weak positive correlation between cell size and rate of glycolysis.

APA, Harvard, Vancouver, ISO, and other styles

10

Nanni, Cristina. "PET-FDG: Impetus." Cancers 12, no. 4 (2020): 1030. http://dx.doi.org/10.3390/cancers12041030.

Full text

Abstract:

The International Myeloma Working Group (IMWG)recommends FDG PET/CT (Fluoro-Deoxy-glucose Positron Emission Tomography/Computed Tomography) as the gold standard imaging modality for initial evaluation and response to therapy assessment in multiple myeloma. In fact, FDG PET/CT, provides multiple useful indexes to risk-stratify patients and has significant prognostic value. However, multiple myeloma remains a complex disease to interpret on imaging. The Italian myeloma criteria for PET use (IMPeTUs) were proposed to standardize FDG PET/CT reading in multiple myeloma. In this communication an ove

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "FDG (fluoro-deoxy glucose)"

1

Dullaart, Robin P. F., Marcel Nijland, Philip M. Kluin, and Andor W. J. M. Glaudemans. "23. A 45-year-old Woman with Recurrent Thromboembolic Events and Increased Adrenal 2-[fluorine 18] fluoro-2-deoxy-D glucose (18F-FDG) Uptake." In Diagnostic Dilemmas: Images in Endocrinology. The Endocrine Society, 2013. http://dx.doi.org/10.1210/dde2.9781936704590.ch23.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Mosconi Lisa, Berti Valentina, McHugh Pauline, Pupi Alberto, and de Leon Mony J. "A Tale of Two Tracers: Glucose Metabolism and Amyloid Positron Emission Tomography Imaging in Alzheimer's Disease." In Advances in Alzheimer’s Disease. IOS Press, 2011. https://doi.org/10.3233/978-1-60750-793-2-219.

Full text

Abstract:

The development of prevention therapies for Alzheimer's disease (AD) would greatly benefit from biomarkers that are sensitive to subtle brain changes occurring prior to the onset of clinical symptoms, when the potential for preservation of function is at the greatest. In vivo brain imaging is a promising tool for the early detection of AD through visualization of abnormalities in brain structure, function and histopathology. Currently, Positron Emission Tomography (PET) imaging with amyloid-beta (A&beta;) tracers and 2-[18F]fluoro-2-Deoxy-D-glucose (FDG) is largely utilized in the early an

APA, Harvard, Vancouver, ISO, and other styles

3

Fernandes, Mariana, Agostino Chiaravalloti, Natalia Manfredi, et al. "Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer’s Disease Biomarkers." In Handbook of Prevention and Alzheimer’s Disease. IOS Press, 2024. http://dx.doi.org/10.3233/aiad230032.

Full text

Abstract:

Background: Sleep disorders may cause dysregulation in cerebral glucose metabolism and synaptic functions, as well as alterations in cerebrospinal fluid (CSF) biomarker levels. Objective: This study aimed at measuring sleep, CSF Alzheimer’s disease (AD) biomarkers, and cerebral glucose consumption in patients with obstructive sleep apnea syndrome (OSAS) and patients with periodic limb movement disorder (PLMD), compared to controls. Methods: OSAS and PLMD patients underwent 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET), polysomnographic monitoring, and lumbar puncture

APA, Harvard, Vancouver, ISO, and other styles

4

Subburaj, Kiruthika, Venkata Subramanian Krishnaraju, and Anjugam Alagappan. "Radiopharmaceuticals in Dermatologic Imaging and Therapy." In Targeted Radiopharmaceuticals and Imaging. Royal Society of Chemistry, 2025. https://doi.org/10.1039/9781837677139-00382.

Full text

Abstract:

Skin is an organ system, which includes not only the skin but also its associated appendages, like hair and nails. These are sites of a wide range of both benign and malignant disease processes. Nuclear medicine plays a vital role in diagnosis, prognostication, response assessment and surveillance of malignant conditions, such as melanoma and other non-melanoma skin cancers. [18F]2-fluoro-2-deoxy glucose ([18F]FDG) positron emission tomography (PET)–computerized tomography (CT) is the cornerstone of oncology practice and is supplemented by a wide variety of newly developed radiopharmaceuticals

APA, Harvard, Vancouver, ISO, and other styles

5

Høilund-Carlsen, Poul F., Abass Alavi, and Jorge R. Barrio. "PET/CT/MRI in Clinical Trials of Alzheimer’s Disease." In Advances in Alzheimer’s Disease. IOS Press, 2024. https://doi.org/10.3233/aiad240044.

Full text

Abstract:

With the advent of PET imaging in 1976, 2-deoxy-2-[18F]fluoro-D-glucose (FDG)-PET became the preferred method for in vivo investigation of cerebral processes, including regional hypometabolism in Alzheimer’s disease. With the emergence of amyloid-PET tracers, [11C]Pittsburgh Compound-B in 2004 and later [18F]florbetapir, [18F]florbetaben, and [18F]flumetamol, amyloid-PET has replaced FDG-PET in Alzheimer’s disease anti-amyloid clinical trial treatments to ensure “amyloid positivity” as an entry criterion, and to measure treatment-related decline in cerebral amyloid deposits. MRI has been used

APA, Harvard, Vancouver, ISO, and other styles

6

Triumbari, Elizabeth Katherine Anna, Agostino Chiaravalloti, Orazio Schillaci, Nicola Biagio Mercuri, and Claudio Liguori. "Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer’s Disease: An Overview of the Current State of the Art of Research." In Advances in Alzheimer’s Disease. IOS Press, 2024. https://doi.org/10.3233/aiad240045.

Full text

Abstract:

The integration of positron emission tomography/computed tomography (PET/CT) has revolutionized the landscape of Alzheimer’s disease (AD) research and therapeutic interventions. By combining structural and functional imaging, PET/CT provides a comprehensive understanding of disease pathology and response to treatment assessment. PET/CT, particularly with 2-deoxy-2-[fluorine-18]fluoro-D-glucose (18F-FDG), facilitates the visualization of glucose metabolism in the brain, enabling early diagnosis, staging, and monitoring of neurodegenerative disease progression. The advent of amyloid and tau PET

APA, Harvard, Vancouver, ISO, and other styles

7

Robbins, Richard J., Chee-Yeung Chan, R. Michael Tuttle, and Steven M. Larson. "Chapter 6 The role of fluoro-deoxy glucose (FDG) positron emission tomography (PET) in the management of differentiated thyroid cancer." In Advances in Molecular and Cellular Endocrinology. Elsevier, 2006. http://dx.doi.org/10.1016/s1569-2566(04)04006-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Faheem, Mohd, Vaibhav Pandey, and Manish Dixit. "[ ¹⁸F]Fluoro Analogue of D-Glucose: A Chemistry Perspective." In 2-Deoxy-D-Glucose: Chemistry and Biology. BENTHAM SCIENCE PUBLISHERS, 2024. http://dx.doi.org/10.2174/9789815305159124010007.

Full text

Abstract:

2-[18F]fluoro-D-glucose ([18F]FDG) is a versatile molecule in nuclear medicine that has evolved into a vital radiotracer in medical imaging applications via positron emission tomography (PET) [18F]FDG is derived from its derivative, 2-deoxyD-glucose (2-DG), where the triflate group is attached to carbon-2 [18F]FDG serves as a crucial non-invasive diagnostic tool and is prominently utilized in non-invasive imaging of various metastatic diseases, particularly cancer imaging. Its importance as a tracer has been further enhanced by its unexpected attribute of generating a low body background throu

APA, Harvard, Vancouver, ISO, and other styles

9

King, KS, DK Alexopoulos, MA Whatley, et al. "Functional Imaging of Head and Neck Paragangliomas: Comparison of18F-Fluorodihydroxyphenylalanine (18F-FDOPA) Positron Emission Tomography (PET),18F-Fluorodopamine (18F-FDA) PET/Computed Tomography (CT),18F-Fluoro-2-Deoxy-D-Glucose (18F-FDG) PET/CT,123I-Metaiodobenzylguanidine (123I-MIBG) Scintigraphy, and 111In-Pentetreotide Scintigraphy." In The Endocrine Society's 92nd Annual Meeting, June 19–22, 2010 - San Diego. Endocrine Society, 2010. http://dx.doi.org/10.1210/endo-meetings.2010.part2.or.or14-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "FDG (fluoro-deoxy glucose)"

1

Patel, Maryam, Bawanile Hadebe, Venesen Pillay, and Lerwine Harry. "Should 18F-FDG PET/CT Scans (2-Deoxy-2[fluorine 18] fluoro-D-glucose Integrated with Computed Tomography) Replace 99mTc-MDP (Methylene Diphosphonate) Bone Scintigraphy in the Management of Breast Cancer Patients with Suspected Skeletal Metastases?" In Abstracts for the 18th International Conference on Radiopharmaceutical Therapy (ICRT). Thieme Medical and Scientific Publishers Pvt. Ltd., 2023. http://dx.doi.org/10.1055/s-0043-1769982.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!